Literature DB >> 16935963

Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works.

B M Carruthers1.   

Abstract

A perspective on the various definitions of myalgic encephalomyelitis and the process of discovering its aetiology is presented. The importance of clinical guidelines is emphasised to encourage clinicians to provide clear descriptions of their individual patients required for proper clinical activity; diagnosis, estimation of severity of effect, prognosis, treatment and rehabilitation. This individual knowledge is informed by general and (hopefully) publicly confirmed knowledge resulting from scientific research during the second-person interaction which lies at the core of the clinical encounter. Both types of knowledge are essential.

Entities:  

Mesh:

Year:  2006        PMID: 16935963      PMCID: PMC1860613          DOI: 10.1136/jcp.2006.042754

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Chronic fatigue syndrome: a working case definition.

Authors:  G P Holmes; J E Kaplan; N M Gantz; A L Komaroff; L B Schonberger; S E Straus; J F Jones; R E Dubois; C Cunningham-Rundles; S Pahwa
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

2.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

3.  The clinical application of the biopsychosocial model.

Authors:  G L Engel
Journal:  Am J Psychiatry       Date:  1980-05       Impact factor: 18.112

4.  A report--chronic fatigue syndrome: guidelines for research.

Authors:  M C Sharpe; L C Archard; J E Banatvala; L K Borysiewicz; A W Clare; A David; R H Edwards; K E Hawton; H P Lambert; R J Lane
Journal:  J R Soc Med       Date:  1991-02       Impact factor: 18.000

  4 in total
  39 in total

Review 1.  Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.

Authors:  Andrew S Papadopoulos; Anthony J Cleare
Journal:  Nat Rev Endocrinol       Date:  2011-09-27       Impact factor: 43.330

2.  C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Melanie Uhde; Alyssa Indart; Brian A Fallon; Gary P Wormser; Adriana R Marques; Suzanne D Vernon; Armin Alaedini
Journal:  Clin Infect Dis       Date:  2018-09-28       Impact factor: 9.079

3.  Anti-neural antibody response in patients with post-treatment Lyme disease symptoms versus those with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Mary Ajamian; Michael Cooperstock; Gary P Wormser; Suzanne D Vernon; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2015-04-10       Impact factor: 7.217

4.  No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology.

Authors:  Jonas Blomberg; Fredrik Blomberg; Anna Sjösten; Ali Sheikholvaezin; Agnes Bölin-Wiener; Amal Elfaitouri; Sanna Hessel; Carl-Gerhard Gottfries; Olof Zachrisson; Christina Ohrmalm; Magnus Jobs; Rüdiger Pipkorn
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

5.  Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?

Authors:  Nneka Orji; Julie A Campbell; Karen Wills; Martin Hensher; Andrew J Palmer; Melissa Rogerson; Ryan Kelly; Barbara de Graaff
Journal:  BMC Public Health       Date:  2022-08-09       Impact factor: 4.135

6.  Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls.

Authors:  A S Bradley; B Ford; A S Bansal
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

7.  A Chronic Fatigue Syndrome (CFS) severity score based on case designation criteria.

Authors:  James N Baraniuk; Oluwatoyin Adewuyi; Samantha Jean Merck; Mushtaq Ali; Murugan K Ravindran; Christian R Timbol; Rakib Rayhan; Yin Zheng; Uyenphuong Le; Rania Esteitie; Kristina N Petrie
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

8.  Chronic Fatigue Syndrome prevalence is grossly overestimated using Oxford criteria compared to Centers for Disease Control (Fukuda) criteria in a U.S. population study.

Authors:  James N Baraniuk
Journal:  Fatigue       Date:  2017-07-21

9.  Murine gammaretrovirus group G3 was not found in Swedish patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia.

Authors:  Amal Elfaitouri; Xingwu Shao; Johan Mattsson Ulfstedt; Shaman Muradrasoli; Agnes Bölin Wiener; Sultan Golbob; Christina Ohrmalm; Michael Matousek; Olof Zachrisson; Carl-Gerhard Gottfries; Jonas Blomberg
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

10.  Evolving perspectives on lyme borreliosis in Canada.

Authors:  Jlh Sperling; Mj Middelveen; D Klein; Fah Sperling
Journal:  Open Neurol J       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.